isocarboxazid has been researched along with Nervous System Disorders in 2 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bodner, RA | 1 |
| Lynch, T | 1 |
| Lewis, L | 1 |
| Kahn, D | 1 |
| Brannan, SK | 1 |
| Talley, BJ | 1 |
| Bowden, CL | 1 |
2 other studies available for isocarboxazid and Nervous System Disorders
| Article | Year |
|---|---|
Serotonin syndrome.
Topics: Depressive Disorder; Humans; Isocarboxazid; Male; Methylphenidate; Middle Aged; Nervous System Disea | 1995 |
Sertraline and isocarboxazid cause a serotonin syndrome.
Topics: 1-Naphthylamine; Adult; Drug Interactions; Female; Humans; Isocarboxazid; Nervous System Diseases; S | 1994 |